A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus
Clinical trial NCT02938572 · COMPLETED
Trial details
- NCT number
- NCT02938572
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-19
- Primary completion
- 2017-06-17
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.